Home › Synovial Sarcoma
Pag-aaral pangklinika para sa Synovial Sarcoma na nagre-recruit sa U.S.
13 pag-aaral para sa Synovial Sarcoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Boston, MA5 pag-aaral
- Chicago, IL4 pag-aaral
- Houston, TX4 pag-aaral
- St. Louis, MO3 pag-aaral
- New York City, NY3 pag-aaral
Ayos sa estado
- California5 pag-aaral
- Illinois4 pag-aaral
- Massachusetts5 pag-aaral
- Missouri3 pag-aaral
- New York3 pag-aaral
- Pennsylvania3 pag-aaral
- Texas4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT05711615First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06644755N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
Nagre-recruitMaagang Phase 1
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07261657SPEARHEAD-3 Pediatric Study
Nagre-recruitPhase 1/2
Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05642455NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06239272Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
Nagre-recruitPhase 1
Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT06083883AOH1996 for the Treatment of Refractory Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT05227326Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Nagre-recruitPhase 1/2
6 Months – 25 Years · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT06625190XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT06571734Synovial Sarcoma Registry / Biospecimen Repository
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hun 9, 2026 · NCT05910307Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 25, 2026 · NCT03016819HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
Nagre-recruitPhase 1
Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Ene 22, 2026 · NCT04995003ACTengine® IMA203 Combined With mRNA-4203
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 8, 2026 · NCT06946225Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.